文献速递认知障碍与痴呆神经免疫

炎症性疾病、炎症生物标志物与阿尔茨海默病:一项观察性分析与孟德尔随机化研究

Inflammatory Diseases, Inflammatory Biomarkers, and Alzheimer Disease: An Observational Analysis and Mendelian Randomization.
PubMed 文献 · Neurology · 2022-11-16

研究利用英国临床实践研究数据链2047513名参与者进行观察性分析,并利用15个全基因组关联研究数据集逾110万人进行两样本孟德尔随机化,发现炎症性疾病与AD风险升高相关(如IBD HR 1.17),但遗传预测的炎症性疾病风险与AD风险无关,提示关联可能由混杂所致。

要点

  • 观察性分析显示炎症性肠病、银屑病、类风湿关节炎等患者AD发病率较高。
  • 遗传预测的炎症性疾病风险与AD风险无关,提示观察到的关联不太可能为因果。
  • 循环MIG水平与AD风险呈提示性关联(OR 1.23),但证据较弱。

核心结论

  • 数据提示炎症性疾病与AD风险之间的关联不太可能为因果,可能由混杂导致。
  • 尽管炎症生物标志物与炎症性疾病存在因果关联证据,但其同时影响炎症性疾病和AD的证据较弱。

研究设计与样本

  • 观察性分析使用英国临床实践研究数据链(CPRD)中2047513名参与者数据,评估慢性自身免疫炎症性疾病与AD风险的关系。
  • 两样本孟德尔随机化使用来自15个大规模全基因组关联研究数据集的总计超过1100000名个体数据,探究慢性自身免疫炎症性疾病、循环炎症生物标志物水平与AD风险的关系。

主要发现

  • 与年龄(±5岁)和性别匹配且无所有待研究炎症性疾病的对照组相比,炎症性肠病患者AD总体发病率更高(HR 1.17;95%CI 1.15-1.19;p=2.1×10-4)。
  • 其他炎性多关节病和系统性结缔组织病患者AD风险较对照组升高(HR 1.13;95%CI 1.12-1.14;p=8.6×10-5)。
  • 银屑病患者AD风险较对照组升高(HR 1.13;95%CI 1.10-1.16;p=2.6×10-4)。
  • 类风湿关节炎患者AD风险较对照组升高(HR 1.08;95%CI 1.06-1.11;p=4.0×10-4)。
  • 多发性硬化患者AD风险较对照组升高(HR 1.06;95%CI 1.04-1.07;p=2.8×10-4)。

关键数值与推荐

  • 循环干扰素γ诱导单核因子(MIG)水平与AD风险升高呈提示性关联(逆方差加权OR 1.23;95%CI 1.06-1.42;p值=0.007)。
  • 循环MIG水平与克罗恩病风险降低相关(逆方差加权OR 0.73;95%CI -0.62至0.86;p值=1.3×10-4)。
  • 共定位分析支持MIG与克罗恩病存在共同因果单核苷酸多态性(后验概率=0.74),但与AD不存在(后验概率=0.03)。
  • 采用两样本孟德尔随机化方法,遗传预测的炎症性疾病风险与AD风险升高无关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Whether chronic autoimmune inflammatory diseases causally affect the risk of Alzheimer disease (AD) is controversial. We characterized the relationship between inflammatory diseases and risk of AD and explored the role of circulating inflammatory biomarkers in the relationships between inflammatory diseases and AD. METHODS: We performed observational analyses for chronic autoimmune inflammatory diseases and risk of AD using data from 2,047,513 participants identified in the UK Clinical Practice Research Datalink (CPRD). Using data of a total of more than 1,100,000 individuals from 15 large-scale genome-wide association study data sets, we performed 2-sample Mendelian randomizations (MRs) to investigate the relationships between chronic autoimmune inflammatory diseases, circulating inflammatory biomarker levels, and risk of AD. RESULTS: Cox regression models using CPRD data showed that the overall incidence of AD was higher among patients with inflammatory bowel disease (hazard ratio [HR] 1.17; 95% CI 1.15-1.19; p = 2.1 × 10-4), other inflammatory polyarthropathies and systematic connective tissue disorders (HR 1.13; 95% CI 1.12-1.14; p = 8.6 × 10-5), psoriasis (HR 1.13; 95% CI 1.10-1.16; p = 2.6 × 10-4), rheumatoid arthritis (HR 1.08; 95% CI 1.06-1.11; p = 4.0 × 10-4), and multiple sclerosis (HR 1.06; 95% CI 1.04-1.07; p = 2.8 × 10-4) compared with the age (±5 years) and sex-matched comparison groups free from all inflammatory diseases under investigation. Bidirectional MR analysis identified relationships between chronic autoimmune inflammatory diseases and circulating inflammatory biomarkers. Particularly, circulating monokine induced by gamma interferon (MIG) level was suggestively associated with a higher risk of AD (odds ratio from inverse variance weighted [ORIVW] 1.23; 95% CI 1.06-1.42; p IVW = 0.007) and lower risk of Crohn disease (ORIVW 0.73; 95% CI -0.62 to 0.86; p IVW = 1.3 × 10-4). Colocalization supported a common causal single nucleotide polymorphism for MIG and Crohn disease (posterior probability = 0.74), but not AD (posterior probability = 0.03). Using a 2-sample MR approach, genetically predicted risks of inflammatory diseases were not associated with higher AD risk. DISCUSSION: Our data suggest that the association between inflammatory diseases and risk of AD is unlikely to be causal and may be a result of confounding. In support, although inflammatory biomarkers showed evidence for causal associations with inflammatory diseases, evidence was weak that they affected both inflammatory disease and AD.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Huang J, Su B, Karhunen V, et al. Inflammatory Diseases, Inflammatory Biomarkers, and Alzheimer Disease: An Observational Analysis and Mendelian Randomization. Neurology. 2022. PMID: 36384659. doi:10.1212/WNL.0000000000201489

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。